Effect of ACE Genotype on Cardiovascular Rehabilitation (ACE-REHAB)
Effects of ACE Genotype on Muscular and Functional Adaptations Following a Cardiovascular Rehabilitation Program
Sponsor: Balgrist University Hospital
Terminated
Study terminated
Other terminated trials from Balgrist University Hospital
Other Cardiovascular Disease trials with similar outcome
A PHASE2 clinical study on Cardiovascular Disease, this trial is terminated or withdrawn. The trial is conducted by Balgrist University Hospital and has accumulated 7 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Sep 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Unknown Status → Terminated
-
Jan 2021 — Sep 2023 [monthly]
Unknown Status PHASE2
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Balgrist University Hospital
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .